Tendinitis
📧 Sign up to get email alerts when something new happens for Tendinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Efficacy and Safety of Etoricoxib/Betamethasone Combination in Acute Bursitis, Tendinitis and Synovitis [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of an etoricoxib/betamethasone combination for acute bursitis, tendinitis, and synovitis; …
-
FDA approval · 2025-10-03FDA Approved: NAPROXEN — Original Application (Aurobindo Pharma Limited)
FDA approved Naproxen from Aurobindo Pharma Limited as an original generic application (ANDA 216504). Naproxen is a nonsteroidal anti-inflam…
-
FDA approval · 2025-02-24FDA Approved: INDOMETHACIN — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's original application for Indomethacin, authorizing a generic version of the NSAID with the same…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Efficacy of NSAID Peritendinous Injection for Acute Tendinitis [NA]
A clinical trial update describes evaluating the efficacy of an NSAID injected around the tendon for acute tendinitis; the study is currentl…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Pecs II Block Versus Surgeon Infiltration for Open Subpectoral Biceps Tenodesis [Phase 4]
A Phase 4 trial comparing PECS II block versus surgeon infiltration for open subpectoral biceps tenodesis has completed and results have bee…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Embo Registry; National Registry for Artery Embolization
Clinical trial registry update for the Embo Registry and National Registry for Artery Embolization. It lists recruiting status for chronic p…
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Protein Turnover in Healthy and Overuse-diseased Tendon [NA]
A completed clinical trial at Bispebjerg Hospital studied protein turnover in healthy versus overuse-diseased tendons. The conditions includ…
-
FDA approval · 2022-09-06FDA Approved: NAPROXEN SODIUM — Supplemental Application (CVS)
The FDA approved a supplemental application for naproxen sodium sponsored by CVS.
-
FDA approval · 2020-10-28FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Aleve GelCaps (naproxen sodium) as a new gelcap dosage form for naproxen sodium, expanding th…
-
FDA approval · 2020-07-28FDA Approved: NAPROXEN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Naproxen from Glenmark Pharmaceuticals to update the labeling for the generic product under the …
-
FDA approval · 2020-03-19FDA Approved: NAPROXEN — Supplemental Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's supplemental application for naproxen (generic) under ANDA075390. This action constitutes a suppleme…
-
FDA approval · 2019-11-15FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for a generic Naproxen product from Hikma Pharmaceuticals USA Inc. This action expands access to…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: A Prospective Comparison of Ultrasound-Guided Percutaneous Platelet-Rich Plasma Injection [Phase 2]
Phase 2 clinical trial evaluating ultrasound-guided percutaneous platelet-rich plasma injections for tendinopathy (tendinosis and tendinitis…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Long Duration Therapeutic Ultrasound for Tendon Healing [NA]
A completed clinical trial evaluating long duration therapeutic ultrasound for tendon healing conducted by ZetrOZ, Inc. has been updated.
-
FDA approval · 2016-05-09FDA Approved: NAPROXEN — Supplemental Application (Zameer Pharmaceuticals LLC)
FDA approved a supplemental application for Naproxen submitted by Zameer Pharmaceuticals LLC.
-
CLINICAL_TRIALS withdrawal · 2015-06-23Clinical Trial Update: Comparison of 2 Doses of Corticosteroid Subacromial Injections for the Treatment of Painful Shoulder [NA]
A clinical trial comparing two doses of corticosteroid subacromial injections for painful shoulder has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Epidemiology of Incidents and Accidents in Sport. Influence of Moisture. [Phase 3]
Phase 3 clinical trial update examining how moisture influences the incidence of sports-related injuries such as fractures, sprains, stress …
-
FDA approval · 2014-11-02FDA Approved: NAPROXEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Naproxen by Amneal Pharmaceuticals of New York LLC (generic Naproxen).
-
FDA approval · 2014-10-16FDA Approved: INDOCIN — Supplemental Application (Zyla Life Sciences US LLC)
FDA approved a supplemental application for Indocin (indomethacin) submitted by Zyla Life Sciences US LLC.
-
CLINICAL_TRIALS research · 2010-04-16Clinical Trial Update: To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury. [Phase 3]
Phase 3 clinical trial comparing Aliviador to Gelol in patients with contusions, sprains, trauma, and muscle injuries; trial status is unkno…
-
FDA approval · 2010-03-17FDA Approved: INDOMETHACIN — Original Application (Fresenius Kabi USA, LLC)
The FDA approved an original NDA for indomethacin from Fresenius Kabi USA, LLC. The approval covers indications for inflammatory and musculo…
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: Efficacy and Safety of Salonsip Compared to Sabiá Plaster [Phase 3]
A Phase 3 trial compares Salonsip with Sabiá Plaster to assess efficacy and safety; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2008-08-14Clinical Trial Update: Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis [Phase 3]
Phase 3 trial evaluating a 20% ketoprofen topical patch for pain due to tendinitis or bursitis has been terminated.
-
FDA approval · 2007-09-25FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Naproxen from Hikma Pharmaceuticals USA Inc., indicating an approved change or addition to the N…
-
FDA approval · 2007-03-28FDA Approved: NAPROXEN — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's naproxen generic under an original ANDA, enabling market access for generic naproxen products.